Breast and ovarian cancer: Y do we forget about dad?

The Lancet Oncology

Volumn 11, Issue 12, 2010, Pages 1115-1117

  McCuaig, Jeanna M ^a,e   Greenwood, Celia ^b,c   Shuman, Cheryl ^d,e   Chitayat, David ^d,e,g   Joan Murphy, K ^a,f   Rosen, Barry ^a,f   Armel, Susan Randall ^a,e  

^a Departments of Radiation Oncology and Medical Biophysics   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AWARENESS; BREAST CANCER; CANCER SUSCEPTIBILITY; DISEASE TRANSMISSION; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; NOTE; OVARY CANCER; PLESIOMORPHY; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, Y; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; OVARIAN NEOPLASMS;

EID: 78649635807     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70246-1     Document Type: Note

References (14)

1. Fast stats GLOBOCAN 2008, (accessed Sept 30, 2010). http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=901.
2. Slattery ML, Kerber RA A comprehensive evaluation of family history of breast cancer risk. The Utah Population Database. JAMA 1993, 270:1563-1568.
3. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
4. Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999, 91:943-949.
5. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
6. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792.
7. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Gen 1998, 62:676-689.
8. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Gen 2005, 42:749-755.
9. Yong MC, Zhou XJ, Lee SC The importance of paternal family history in hereditary breast cancer is underappreciated by health care professionals. Oncology 2003, 64:220-226.
10. Burke W, Culver J, Pinsky L, et al. Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A 2009, 149A:349-356.
11. Katapodi MC, Aouizerat BE Do women in the community recognize hereditary and sporadic breast cancer risk factors?. Oncol Nurs Forum 2005, 32:617-623.
12. O'Neill SM, Peters JA, Vogel VG, Feingold E, Rubinstein WS Referral to cancer genetic counseling: are there stages of readiness?. Am J Med Genet C Semin Med Genet 2006, 142C:221-231.
13. Huang GJ, Penson DF Internet health resources and the cancer patient. Cancer Invest 2008, 26:202-207.
14. Fodor FH, Weston A, Bleiweiss IJ, et al. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Gen 1998, 63:45-51.